Antigen Long Description: Oxelumab binds to human OX40L, the ligand of OX40, stimulatory receptor that is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells.
Buffer Composition: PBS only.
Chimeric Use Statement: NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.